INDP — Indaptus Therapeutics Balance Sheet
0.000.00%
- $7.38m
- $1.59m
Annual balance sheet for Indaptus Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 14.7 | 39.1 | 26.4 | 13.4 | 5.79 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.085 | — | — | — | — |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 15 | 40.4 | 27.2 | 14 | 6.62 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2.21 | 0.173 | 0.081 | 0.174 | 0.082 |
Other Long Term Assets | |||||
Total Assets | 20.9 | 40.6 | 28.1 | 14.9 | 7.34 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5.33 | 4.6 | 3.43 | 2.77 | 3.39 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 6.36 | 4.68 | 3.43 | 2.85 | 3.39 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 14.5 | 35.9 | 24.6 | 12.1 | 3.94 |
Total Liabilities & Shareholders' Equity | 20.9 | 40.6 | 28.1 | 14.9 | 7.34 |
Total Common Shares Outstanding |